364 related articles for article (PubMed ID: 10837435)
1. Comparison of efficacy of ciprofloxacin and doxycycline against experimental melioidosis and glanders.
Russell P; Eley SM; Ellis J; Green M; Bell DL; Kenny DJ; Titball RW
J Antimicrob Chemother; 2000 Jun; 45(6):813-8. PubMed ID: 10837435
[TBL] [Abstract][Full Text] [Related]
2. [In vitro antibiotic susceptibility compliance with efficacy of chemotherapy in infections due to pathogenic Burkholderias].
Iliukhin VI; Senina TV; Trushkina MN; Shubnikova EV; Antonov IuV; Andropova NV
Antibiot Khimioter; 2009; 54(7-8):19-23. PubMed ID: 20201399
[TBL] [Abstract][Full Text] [Related]
3. The efficacy of ciprofloxacin and doxycycline against experimental tularaemia.
Russell P; Eley SM; Fulop MJ; Bell DL; Titball RW
J Antimicrob Chemother; 1998 Apr; 41(4):461-5. PubMed ID: 9598777
[TBL] [Abstract][Full Text] [Related]
4. Burkholderia mallei and Burkholderia pseudomallei: the causative micro-organisms of glanders and melioidosis.
Gilad J
Recent Pat Antiinfect Drug Discov; 2007 Nov; 2(3):233-41. PubMed ID: 18221181
[TBL] [Abstract][Full Text] [Related]
5. Doxycycline or ciprofloxacin prophylaxis and therapy against experimental Yersinia pestis infection in mice.
Russell P; Eley SM; Bell DL; Manchee RJ; Titball RW
J Antimicrob Chemother; 1996 Apr; 37(4):769-74. PubMed ID: 8722542
[TBL] [Abstract][Full Text] [Related]
6. In vitro susceptibilities of Burkholderia mallei in comparison to those of other pathogenic Burkholderia spp.
Kenny DJ; Russell P; Rogers D; Eley SM; Titball RW
Antimicrob Agents Chemother; 1999 Nov; 43(11):2773-5. PubMed ID: 10543761
[TBL] [Abstract][Full Text] [Related]
7. Present and future therapeutic strategies for melioidosis and glanders.
Estes DM; Dow SW; Schweizer HP; Torres AG
Expert Rev Anti Infect Ther; 2010 Mar; 8(3):325-38. PubMed ID: 20192686
[TBL] [Abstract][Full Text] [Related]
8. Antibiotic resistance in Burkholderia species.
Rhodes KA; Schweizer HP
Drug Resist Updat; 2016 Sep; 28():82-90. PubMed ID: 27620956
[TBL] [Abstract][Full Text] [Related]
9. Rapid antimicrobial susceptibility testing and β-lactam-induced cell morphology changes of Gram-negative biological threat pathogens by optical screening.
McLaughlin HP; Sue D
BMC Microbiol; 2018 Dec; 18(1):218. PubMed ID: 30563467
[TBL] [Abstract][Full Text] [Related]
10. Antibiotic susceptibility of 65 isolates of Burkholderia pseudomallei and Burkholderia mallei to 35 antimicrobial agents.
Thibault FM; Hernandez E; Vidal DR; Girardet M; Cavallo JD
J Antimicrob Chemother; 2004 Dec; 54(6):1134-8. PubMed ID: 15509614
[TBL] [Abstract][Full Text] [Related]
11. [Burkholderia mallei and Burkholderia pseudomallei. Study of immuno- and pathogenesis of glanders and melioidosis. Heterologous vaccines].
Manzeniuk IN; Galina EA; Dorokhin VV; Kalachev IIa; Borzenkov VN; Svetoch EA
Antibiot Khimioter; 1999; 44(6):21-6. PubMed ID: 10422574
[TBL] [Abstract][Full Text] [Related]
12. Recombinant Salmonella Expressing Burkholderia mallei LPS O Antigen Provides Protection in a Murine Model of Melioidosis and Glanders.
Moustafa DA; Scarff JM; Garcia PP; Cassidy SK; DiGiandomenico A; Waag DM; Inzana TJ; Goldberg JB
PLoS One; 2015; 10(7):e0132032. PubMed ID: 26148026
[TBL] [Abstract][Full Text] [Related]
13. [Fluoroquinolones: antimicrobial activity and chemotherapeutic efficacy with respect to various pathogens in highly dangerous diseases].
Bondareva TA; Kalininskiĭ VB; Borisevich IV; Bondarev VP; Kozhukhov VV; Amosov MIu; Baramzina GV; Fomenkov OO; Krinitsyn FV
Antibiot Khimioter; 2007; 52(11-12):21-4. PubMed ID: 19275053
[TBL] [Abstract][Full Text] [Related]
14. Comparative experimental subcutaneous glanders and melioidosis in the common marmoset (Callithrix jacchus).
Nelson M; Salguero FJ; Dean RE; Ngugi SA; Smither SJ; Atkins TP; Lever MS
Int J Exp Pathol; 2014 Dec; 95(6):378-91. PubMed ID: 25477002
[TBL] [Abstract][Full Text] [Related]
15. [Identification of the causative agents of glanders and melioidosis by polymerase chain reaction].
Tkachenko GA; Antonov VA; Zamaraev VS; Iliukhin VI
Mol Gen Mikrobiol Virusol; 2003; (3):18-22. PubMed ID: 12966921
[TBL] [Abstract][Full Text] [Related]
16. Pathogenesis of Burkholderia pseudomallei and Burkholderia mallei.
Larsen JC; Johnson NH
Mil Med; 2009 Jun; 174(6):647-51. PubMed ID: 19585782
[TBL] [Abstract][Full Text] [Related]
17. Multilocus sequence typing and evolutionary relationships among the causative agents of melioidosis and glanders, Burkholderia pseudomallei and Burkholderia mallei.
Godoy D; Randle G; Simpson AJ; Aanensen DM; Pitt TL; Kinoshita R; Spratt BG
J Clin Microbiol; 2003 May; 41(5):2068-79. PubMed ID: 12734250
[TBL] [Abstract][Full Text] [Related]
18. Use of a safe, reproducible, and rapid aerosol delivery method to study infection by Burkholderia pseudomallei and Burkholderia mallei in mice.
Lafontaine ER; Zimmerman SM; Shaffer TL; Michel F; Gao X; Hogan RJ
PLoS One; 2013; 8(10):e76804. PubMed ID: 24098563
[TBL] [Abstract][Full Text] [Related]
19. Protective efficacy of heat-inactivated B. thailandensis, B. mallei or B. pseudomallei against experimental melioidosis and glanders.
Sarkar-Tyson M; Smither SJ; Harding SV; Atkins TP; Titball RW
Vaccine; 2009 Jul; 27(33):4447-51. PubMed ID: 19490962
[TBL] [Abstract][Full Text] [Related]
20. An in situ high-throughput screen identifies inhibitors of intracellular
Bulterys PL; Toesca IJ; Norris MH; Maloy JP; Fitz-Gibbon ST; France B; Toffig B; Morselli M; Somprasong N; Pellegrini M; Schweizer HP; Tuanyok A; Damoiseaux R; French CT; Miller JF
Proc Natl Acad Sci U S A; 2019 Sep; 116(37):18597-18606. PubMed ID: 31439817
[No Abstract] [Full Text] [Related]
[Next] [New Search]